The absolute risk increase was 0.030 and 0.009, respectively; that is, with approximately 33 and 111 patients who are treated with ACE inhibitors, 1 individual patient would present with hypotension and hyperkalemia, respectively, attributable to ACE inhibitor usage. This evidence concerns the gene ACE and hypotensive disorder.